[1]
Sleijfer, S. et al. 2018. Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database. Acta Oncologica. 57, 8 (Aug. 2018), 1117–1126. DOI:https://doi.org/10.1080/0284186X.2018.1449248.